Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 66Genitourinary 35Other hematologic neoplasm 22Thoracic 2Myeloid 2Gynecologic 2Gastrointestinal 2Dermatologic 2Tumor-Agnostic 1Other solid neoplasm 1Breast 1

Conditions

Advanced Solid Tumor 1

Interventions

Injections 54pembrolizumab 39Carboplatin 20Bevacizumab 19Cyclophosphamide 18toripalimab 15tislelizumab 14fludarabine 14Nivolumab 14Cisplatin 14Specimen Handling 13Paclitaxel 13Interviews as Topic 13Pemetrexed 12Standard of Care 11Practice Guidelines as Topic 11Oxaliplatin 11Cetuximab 11Fluorouracil 10atezolizumab 9Educational Status 9Docetaxel 9Capecitabine 9Leucovorin 8Methods 7Etoposide 7Early Intervention, Educational 7spartalizumab 6olaparib 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Prednisone × Other solid neoplasm × Clear all
NCT05279300 2025-08-11

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

CStone Pharmaceuticals

Phase 1 Recruiting
480 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡